AI-generated summary
The authors studied whether breaking down staphyloxanthin, a pigment that protects methicillin-resistant Staphylococcus aureus, with 460 nm light could make the bacteria more vulnerable to reactive oxygen species. They report that this photolysis increased membrane permeability and synergistically killed MRSA together with hydrogen peroxide across several settings, including cell culture and two mouse wound models. The abstract does not state the size of the experiments.
- Who or what was studied
- Methicillin-resistant Staphylococcus aureus (MRSA) in planktonic culture, infected macrophages, stationary-phase cells, persisters, biofilms, and two mouse wound infection models
- Wavelengths
- 460 nm
- Limits stated in the abstract
- The abstract does not report sample sizes or statistical details, and most of the evidence comes from laboratory and mouse models rather than human patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Confronted with the severe situation that the pace of resistance acquisition is faster than the clinical introduction of new antibiotics, health organizations are calling for effective approaches to combat methicillin-resistant Staphylococcus aureus (MRSA) infections. Here, an approach to treat MRSA through photolysis of staphyloxanthin, an antioxidant residing in the microdomain of S. aureus membrane, is reported. This photochemistry process is uncovered through transient absorption imaging and quantitated by absorption spectroscopy, Raman spectroscopy, and mass spectrometry. Photolysis of staphyloxanthin transiently elevates the membrane permeability and renders MRSA highly susceptible to hydrogen peroxide attack. Consequently, staphyloxanthin photolysis by low-level 460 nm light eradicates MRSA synergistically with hydrogen peroxide and other reactive oxygen species. The effectiveness of this synergistic therapy is well validated in MRSA planktonic culture, MRSA-infected macrophage cells, stationary-phase MRSA, persisters, S. aureus biofilms, and two mice wound infection models. Collectively, the work demonstrates that staphyloxanthin photolysis is a new therapeutic platform to treat MRSA infections.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 460 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Reactive oxygen species. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.